Objective: To compare the clinical efficacy and adverse reactions of dienogest levonorgestrel-releasing intrauterine system in treatment adenomyosis. Methods: A total 60 cases adenomyosis admitted to Dezhou Women Children’s Hospital from January 2020 October 2021 were selected randomly divided into two groups (Group Group B), which initiated on system, respectively. The therapeutic effects anal...

The levonorgestrel intrauterine system (LNG IUS) has major advantages and could be a ‘‘game-changer’’ in improving contraceptive choice and use. It faces important challenges, however, including: (1) high commodity cost; (2) often-strong provider resistance to IUDs and difficult programmatic requirements; (3) need for demand creation, including assessing if markedly reduced menstrual bleeding i...

Two intrauterine devices (IUDs) are available in the United States, the levonorgestrel-bearing intrauterine system (Mirena) and the copper-bearing T380A (Paragard). These devices have very low typical-use failure rates but are used by only a minority of women. In particular, there is concern about their use in nulliparous women. We review the available data to address common concerns about usin...

Several options for emergency contraception are available in the United States. This article describes each method, including efficacy, mode of action, safety, side effect profile, and availability. The most effective emergency contraceptive is the copper intrauterine device (IUD), followed by ulipristal acetate and levonorgestrel pills. Levonorgestrel is available for sale without restrictions...

The levonorgestrel-containing intrauterine system is an extremely effective, reversible and safe form of long-term yet reversible birth control. In view of its efficacy, it is a safer alternative to permanent contraceptive methods such as sterilization. It is especially useful in situations where use of estrogen-containing contraceptives is contraindicated. While menstrual disturbances are a co...

International agencies work with host country governments to estimate contraceptive needs and to procure commodities at affordable public-sector prices. Depending on the agency and the registration status of the commodity in the given country, three subdermal contraceptive implants are options for purchase: Jadelle® is a two-rod levonorgestrel implant approved for 5 years of continuous use (Bay...

Christina Wang and colleagues conducted a randomized trial in two centers (California, USA and China) with two treatment groups (non-Chinese and Chinese men, respectively, 40 subjects each group). The primary aim of the study was to compare the efficacy of the combination of the progestin levonorgestrel (LNG) with testosterone (T) implants to that by T implants alone on spermatogenesis suppress...

•Levonorgestrel IUD was effective in treatment of recurrent APA.•No side effects were reported.•No impairments on a subsequent pregnancy were reported.

background: the levonorgestrel-releasing iud can help the treatment of dysmenorrhea by reducing the synthesis of endometrial prostaglandins as a conventional treatment. objective: this study was performed to assess the frequency of dysmenorrhea, satisfaction and quality of life in women using mirena iuds as compared to those using copper iuds. materials and methods: this double-blind randomized...